Latest Views & analysis
More Views & Analysis
Will plausibility reign supreme in Lyrica second medical use patent case?
Pharma needs clarity from the Supreme Court on whether the whole scope of a patent claim must be plausible at the time of the application.
Patient access at risk: should stakeholders take an orchestral approach?
Now is the time to work more harmoniously together to improve patient access to innovative treatments.
